BONE DEMINERALISATION

This adverse event was reported 1048 times

These drugs are most commonly taken by patients reporting BONE DEMINERALISATION:

#	Drug	Count
0	EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE	636
1	TENOFOVIR DISOPROXIL FUMARATE	292
2	EMTRICITABINE AND TENOFOVIR ALAFENAMIDE	240
3	RITONAVIR	215
4	ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE	199
5	ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE	175
6	EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE	124
7	GABAPENTIN	118
8	RALTEGRAVIR	110
9	ATAZANAVIR	104

See all common drugs associated with BONE DEMINERALISATION

BONE DEMINERALISATION is most prevalent among patients taking these drugs:

#	Drug	Count	Frequency
0	EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	3	0.1000
1	DARUNAVIR ETHANOLATE AND COBICISTAT	71	0.0405
2	CHLOPHEDIANOL HCL AND PYRILAMINE MALEATE	1	0.0357
3	VITAMIN A, CALCIUM PANTOTHENATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL SUCCINATE, D-, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, BIOTIN, CYANOCOBALAMIN, SELENIUM, MAGNESIUM OXIDE, ZINC OXIDE, CUPRIC SULFATE, MANGANESE, CHROMIUM, .ALPHA.-LIPOIC ACID, AND LUTEIN	1	0.0270
4	DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE	44	0.0253
5	ATAZANAVIR AND COBICISTAT	6	0.0245
6	EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE	84	0.0235
7	NELFINAVIR MESYLATE	47	0.0225
8	EMTRICITABINE AND TENOFOVIR ALAFENAMIDE	240	0.0213
9	POLYETHYLENE GLYCOL, UNSPECIFIED	2	0.0202

See all drugs enriched for association with BONE DEMINERALISATION

These drug classes are most commonly taken by patients reporting BONE DEMINERALISATION:

#	Drug class	Count
0	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	852
1	Cytochrome P450 3A Inhibitor [EPC]	482
2	Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]	281
3	Protease Inhibitor [EPC]	272
4	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	201
5	Nonsteroidal Anti-inflammatory Drug [EPC]	181
6	Corticosteroid [EPC]	115
7	Proton Pump Inhibitor [EPC]	112
8	Benzodiazepine [EPC]	106
9	Dihydropyridine Calcium Channel Blocker [EPC]	86

See all common drug classes associated with BONE DEMINERALISATION

BONE DEMINERALISATION is most prevalent among patients taking these drug classes:

#	Drug class	Count	Frequency
0	Antidiarrheal [EPC]	4	0.0172
1	Cytochrome P450 3A Inhibitor [EPC]	482	0.0080
2	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	852	0.0076
3	Protease Inhibitor [EPC]	272	0.0061
4	CCR5 Co-receptor Antagonist [EPC]	11	0.0048
5	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	201	0.0041
6	alpha-Hydroxy Acid [EPC]	5	0.0024
7	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	46	0.0019
8	Non-narcotic Antitussive [EPC]	27	0.0016
9	Serotonin-4 Receptor Agonist [EPC]	1	0.0016

See all drug classes enriched for association with BONE DEMINERALISATION